Earth Science Tech, Inc. Enters into a Joint Venture with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
54
Earth Science Tech, Inc. Enters into a Joint Venture with Varsity Group, LLC. Under Its Wholly Owned Subsidiary KannaBidioid Inc.

Hollywood, July 06, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCPINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices enters into a joint venture with Varsity Group, LLC. under KannaBidioid Inc., to synergistically share resources as well as their patent pending Kanna Blend formula.

ETST’s management team came across an opportunity to step into the Recreational Vape/Smoke space which is projected to spend $4.77 billion by 2025 *. Earth Science Tech discovered Varsity Group, LLC ,a Kanna Blend ingredient based E-liquid company that has a Patented Kanna-Blend formula( Kanna Chill ), which is produced in their ISO-9001 cGMP Sunrise, FL lab facility. Earth Science Tech and Varsity Group, LLC have joined forces to formulate KannaBlend-Infused Hemp Derived Naturally occurring cannabidiol (CBD) based E-liquid/Sublingual and Gummy Edibles, hence KannaBidioid, Inc. (KBD). This new exciting First To Market Joint Venture will be a 50/50 partnership, with both revenue and expenses being shared equally. Both parties will be exclusive to each other and work synergistically sharing their resources to be the leading innovative E-liquid/Sublingual and Gummy Edible supplier in this space. Varsity Group, LLC was co-founded by David Plante, who will be the president overseeing ETST’s new subsidiary KannaBidioid, Inc.   Varsity Group, LLC  sets the example for being a world class manufacture for the best E-liquid available. Their proven quality control methods, attentiveness to industry regulations, superior customer service, and industry trade secrets consistently keeps the Kanna Chill brand at the pinnacle of industry standards. Varsity Vapes, founded in January 2016 and headquartered in the sunny state of south Florida, is manufactured under stringent FDA guidelines in a ISO-9001 and cGMP certified facility. With previous backgrounds in pharmaceutical manufacturing, business development, and engineering the company strives to produce the highest quality e-liquid formulations. Developed over the past four years, Varsity is proud to be the world’s first, to introduce a choice to the industry, on whether customers want nicotine or an all natural non-addictive alternative to nicotine. They’ve explored and rigorously studied the industry listening to what customers want, inspiring Varsity to incorporate an effective alternative to nicotine within our line. When a customer tries Varsity Vapes Kanna Chill, they can start to comprehend the difference between the high quality Varsity Vapes Kanna Chill line and other sub-par e-juice blends. Their consistency with correctly blending and developing their own flavor formulations illustrates their competitive advantage over this vast industry. David Plante, Managing Partner and Co-founder of Varsity Group, LLC and ETST KannaBidioid, Inc’s President enthusiastically commented, “I can’t think of a better company to work and join forces with”. Having ETST’s passionate and knowledgeable team, R&D  and distribution capabilities , genuine customer service, and brand building skills definitely offers me a team to truly build a brand and lead the recreational vape/smoke shop space. In addition to their top-tier team, their reputation in the CBD space is nothing short of amazing. Their loyal customers, positive feedback , and consistent high quality really make them key, and I couldn’t feel more fortunate to take part and grow along with them.” Nickolas S. Tabraue, ETST’s President, Director, and COO comments, “This joint venture is pivotal for ETST’s entrance to the recreational CBD arena. We can now enter with not only an amazing Kanna Blend and CBD formula, but also a patent-pending tested blend from Varsity Group, LLC. We feel extremely confident knowing that with David Plante overwatching operations, he will help our new subsidiary, KannaBidiod  rapidly grow”. We’re currently in the design phase with Varsity Group’s strong moving flavors, Strawberry Lemonade, Apple Pie, Lemon Cream, and Grape Berry. We then will commence marketing, manufacturing, and distribution within 3Q2017.” ETST continuously plans on updating its shareholders on the above mentioned new subsidiary, joint venture, and sales as further progress and development occurs. About Earth Science Tech, Inc. (ETST): Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world's best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil. T To learn more please visit:  www.earthsciencetech.com ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST's primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants." ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute cannabis industrial hemp based products. View ETST's accomplishments and reports on its High-Grade CBD Hemp Oil: ( here ) About Earth Science Pharmaceutical:  Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry. To learn more please visit:  www.Earthsciencepharmaceutical.com The accuracy of the MSN-2  medical device for the diagnosis of women with Chlamydia has already been proven via a study of 510 female patients, which showed PCR testing results on paired samples to be identical for 493 (96.6%) of the 510 women. To view this study, visit Evaluation of a Modified Sanitary Napkin as a Sample Self-Collection Device for the Detection of Genital Chlamydial Infection in Women . About Cannabis Therapeutics:  Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide. To learn more please visit: www.Cannabisthera.com   Some of the R&D that Cannabis Therapeutics will target will be treatments for the conditions and disorders of: Pain, Chronic Pain, PTSD, Breast Cancer, Brain Cancer, Anxiety, Depression, Glaucoma, Crohn’s disease, Fatty Liver Diseases, Diabetes, Parkinson' s Disease, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), and Drug Addictions among other things. ETST has chosen to target diseases for which, the benefits of Cannabinoids and/or CBD (Cannabidiol) have already been demonstrated by different groups of researchers around the world. However, it is through ETST’s in vitro study with the University of Central Oklahoma and DV Biologics that results confirm the positive effectiveness of Earth Science Tech’s CBD (Cannabidiol) on breast cancer, immune cell function, and human brain cells by acting as a neuroprotectant as shown in its International Application (PCT) for its Provisional Patent. Thus, as a result by mixing natural molecules and generic pharmaceutical drugs with Cannabinoids and/or CBD (Cannabidiol) we intend to increase the effectiveness of Cannabinoids and/or CBD (Cannabidiol) and improve the treatment of different diseases. The THREE (3) cannabis cannabinoid-based nutraceutical patents and TWO (2) generic pharmaceutical drugs will be based on ETST’s International Application (PCT) for its Provisional Patent named “Cannabidiol Compositions Including Mixtures and Uses Thereof” was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil. This application claims the benefit of ETST U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST U.S. Provisional Application No. 62/102,538, filed January 12, 2015.

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it's unique Kanna Blend and CBD formula. Kanna and CBD synergistically enahnce enhance one another, providing optimal relaxation, an uplifiting uplifting sensation, enahnce increase focus, and help ease with nicotine addiction based on their properties properties.  Website coming soon:  www.kannabidioidinc.com FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products. SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations   Dave Demarest  (305)-546-7640   Earth Science Tech, Inc.   Nickolas S. Tabraue, P/D/COO   (305)-615-2118

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 487

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 46

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 347

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 56

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 62

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

EssilorLuxottica Reports Share Capital and Voting Rights Update

Updated Category News Views 214

Overview of EssilorLuxottica's Share Capital EssilorLuxottica, a prominent global leader in eyewear design, manufacture, and distribution, provides a detailed disclosure of its outstanding share capital and voting rights as of a recent date. This information is essential for shareholders and market watchers to understand the company's governance and share structure. Share...

Continue Reading
WM Technology, Inc. Faces Class Action Lawsuit with SEC Fallout

Updated Category News Views 208

WM Technology, Inc. Faces Legal Challenges Recently, a class action lawsuit has arisen against WM Technology, Inc. (NASDAQ: MAPS), a pivotal player in the online cannabis marketplace. The Pomerantz Law Firm has initiated this legal action on behalf of affected investors. As the case unfolds, individuals who believe they have been impacted by the company's actions are...

Continue Reading
EVgo Targets 2026 for Profitable Future Amid Challenges

Updated Category News Views 554

EVgo Overview EVgo Inc. (NASDAQ: EVGO) has faced recent fluctuations in share price following the announcement of its fiscal third-quarter results. The company operates one of the largest public electric vehicle charging networks in the United States, and it has been navigating a challenging landscape in the EV sector. Financial Performance Analysis In its latest report,...

Continue Reading
CNX Resources Corporation Reveals Financial Updates and Call Schedule

Updated Category News Views 126

CNX Resources Corporation Financial Results Announcement CNX Resources Corporation (NYSE: CNX) is set to unveil its financial results for the fourth quarter of 2025. This important event will take place at 6:45 a.m. Eastern Time on an upcoming Thursday. During this announcement, CNX intends to release a concise press statement that will include essential documents linking...

Continue Reading
Nvidia's Revolutionary AI Dominance and Future Outlook

Updated Category News Views 193

Understanding AI and Nvidia's Impact Since the dawn of the internet, investors have seen many trends come and go, but few have been as impactful as the artificial intelligence (AI) revolution. This groundbreaking technology has sparked interest among both seasoned professionals and everyday investors, all eager to explore its immense potential. It’s estimated that AI...

Continue Reading